Investigating farmers' preferences for the design of agri-environment schemes: a choice experiment approach

In recent decades agri-environment schemes (AES) have become an increasingly important tool for policy makers aiming to reverse the post-war decline in environmental quality on agricultural land. The voluntary nature of such schemes means that the decision of farmers to participate is central to achieving policy objectives. Therefore, this paper uses a choice experiment approach to investigate the role that scheme design can have on encouraging farmers to participate. Choice data was gathered from a survey of farmers in 10 case study areas across the EU and analysed using both mixed logit and latent class models. In general, farmers were found to require greater financial incentives to join schemes with longer contracts or that offer less flexibility or higher levels of paperwork. It was also observed that a large segment of farmers ('low resistance adopters') would be willing to accept relatively small incentive payments for their participation in schemes offering relatively little flexibility and high levels of additional paperwork, when compared to a contrasting segment of 'high resistance adopters'. © 2009 University of Newcastle upon Tyne

Emerging geographies of mobility:The role of regional towns in Greece's 'counterurbanisation story'

Drawing on the ?mobility turn?, research in rural studies has engaged with new explorations of mobilities, beyond the now well-explored counterurbanisation and rural gentrification processes, including local and temporary mobility in diverse socio-economic and cultural contexts. This paper explores past and potential future mobility patterns in two regional towns in non-metropolitan Greece in the context of the ongoing financial crisis. Using a choice experiment, we assess the importance of settlement types, family networks, previous residency in the area, cultural opportunities and change in employment type in informing future mobility decisions. The analysis finds evidence of diverse mobilities, and distinguishes between two predominant mobility groups, i.e. counterurbanisers and local movers. We further look at relocation preferences for the two groups and find similar preferences for regional towns. In this context, we provide evidence for the potential emergence of an alternative, i.e. not rooted in pastoralism, version of the Anglo-American ?rural idyll?.Peer reviewe

Molecular marketing, personalised information and willingness‐to‐pay for functional foods: Vitamin D enriched eggs

Increasingly, the health claims made by food products focus on the marketing of specific molecular enrichments. Research exploring consumers’ willingness to pay (WTP) for health claims assumes that individuals hold perfect information on the benefits of the enrichment, and that their valuations depend solely on whether or not they need to improve their health. While health interventions are aimed at individuals at higher health risk, consumers may be unaware of the health risks that they face, limiting the effectiveness of a generic targeting strategy. Using an orthogonal experimental design, we explore the impact of two factors on the WTP for vitamin D enrichment in eggs: whether the information is person-specific or generic; and the presence of a health claim explaining the vitamin D enrichment. Results indicate that it is the provision of information, not the health claim, that influences WTP. Both generic and personalised information lead to similar increases in the WTP for vitamin D enrichment. While we only observe a direct effect of generic information on the WTP for vitamin D enrichment, personal informa- tion may also operate by increasing the perceived risk of vitamin D deficiency. Our results support the use of personalised health information during the choice task as a means of increasing the sales of healthy products

Modelling zero bids in contingent valuation surveys

When modelling data generated from a discrete choice contingent valuation question, the treatment of zero bids affects the welfare estimates. Zero bids may come from respondents who are not interested in the provision of the public good; alternatively, some zero-bidders may be protesting about the valuation exercise, but hold positive values for the good. In this paper we investigate the effect of different levels of information on zero-bidders on welfare estimates for the population. We find that different strategies of identification may have non-trivial effects. We recommend use of full debriefing questions for zero-bidders, and use of sample selection models to correct for bias caused by protest behaviou

Review of approaches to establish reference levels to interpret indicators

Agricultural and Food Policy, Environmental Economics and Policy, Farm Management, Land Economics/Use,

Heterogeneity of preferences for the benefits of environmental stewardship: a latent-class approach

Since 2005, Environmental Stewardship (ES) has been the principal agri-environment scheme for England and is the key instrument for the delivery of increased environmental benefits from agricultural landscapes. The main objective of this study is to investigate whether or not individuals' preferences for the environmental benefits associated with ES vary depending on types of landscapes within which these benefits are delivered. A latent class model is applied to data obtained from a choice experiment survey of over 1000 respondents sampled across England. The results suggest that individuals have heterogenous preferences for the benefits of ES, though different segments of the population with more homogenous preferences can be identified. In particular, higher levels of benefit are often associated with the operation of ES in landscapes close to where respondents live. This leads to the suggestion that, in order to maximise the benefits of ES, its implementation could take this result into account by encouraging greater uptake from farmers whose land is closer to large populations

Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support-free days in patients hospitalized with COVID-19

IMPORTANCE Overactivation of the renin-angiotensin system (RAS) may contribute to poor clinical outcomes in patients with COVID-19. Objective To determine whether angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) initiation improves outcomes in patients hospitalized for COVID-19. DESIGN, SETTING, AND PARTICIPANTS In an ongoing, adaptive platform randomized clinical trial, 721 critically ill and 58 non–critically ill hospitalized adults were randomized to receive an RAS inhibitor or control between March 16, 2021, and February 25, 2022, at 69 sites in 7 countries (final follow-up on June 1, 2022). INTERVENTIONS Patients were randomized to receive open-label initiation of an ACE inhibitor (n = 257), ARB (n = 248), ARB in combination with DMX-200 (a chemokine receptor-2 inhibitor; n = 10), or no RAS inhibitor (control; n = 264) for up to 10 days. MAIN OUTCOMES AND MEASURES The primary outcome was organ support–free days, a composite of hospital survival and days alive without cardiovascular or respiratory organ support through 21 days. The primary analysis was a bayesian cumulative logistic model. Odds ratios (ORs) greater than 1 represent improved outcomes. RESULTS On February 25, 2022, enrollment was discontinued due to safety concerns. Among 679 critically ill patients with available primary outcome data, the median age was 56 years and 239 participants (35.2%) were women. Median (IQR) organ support–free days among critically ill patients was 10 (–1 to 16) in the ACE inhibitor group (n = 231), 8 (–1 to 17) in the ARB group (n = 217), and 12 (0 to 17) in the control group (n = 231) (median adjusted odds ratios of 0.77 [95% bayesian credible interval, 0.58-1.06] for improvement for ACE inhibitor and 0.76 [95% credible interval, 0.56-1.05] for ARB compared with control). The posterior probabilities that ACE inhibitors and ARBs worsened organ support–free days compared with control were 94.9% and 95.4%, respectively. Hospital survival occurred in 166 of 231 critically ill participants (71.9%) in the ACE inhibitor group, 152 of 217 (70.0%) in the ARB group, and 182 of 231 (78.8%) in the control group (posterior probabilities that ACE inhibitor and ARB worsened hospital survival compared with control were 95.3% and 98.1%, respectively). CONCLUSIONS AND RELEVANCE In this trial, among critically ill adults with COVID-19, initiation of an ACE inhibitor or ARB did not improve, and likely worsened, clinical outcomes. TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT0273570